PLC-beta-IN-1 (Compound 8a) is an inhibitor of PLCbeta that exhibits anti-airway constriction activity by suppressing PLCbeta and its downstream signaling pathways. It also enhances the bronchorelaxant effects of beta-agonists. This compound can be utilized in asthma research.
Target-Kategorie:
Phospholipase
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
